🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/09/1996 | 31,31 | 31,37 | 30,59 | 30,95 | -0,95% | 2,48% | 6.152.808 |
| 05/09/1996 | 31,25 | 31,67 | 31,19 | 31,25 | -0,19% | 1,53% | 2.898.558 |
| 04/09/1996 | 31,13 | 31,43 | 31,01 | 31,31 | +0,77% | 1,34% | 3.386.926 |
| 03/09/1996 | 31,01 | 31,13 | 30,89 | 31,07 | -0,76% | 0,77% | 4.338.091 |
| 30/08/1996 | 31,85 | 31,91 | 31,19 | 31,31 | -1,32% | 2,25% | 2.883.048 |
| 29/08/1996 | 32,20 | 32,26 | 31,61 | 31,73 | -1,85% | 2,04% | 3.087.618 |
| 28/08/1996 | 31,91 | 32,56 | 31,91 | 32,32 | +0,74% | 2,06% | 2.566.342 |
| 27/08/1996 | 31,97 | 32,14 | 31,85 | 32,08 | +0,37% | 0,93% | 2.519.182 |
| 26/08/1996 | 32,32 | 32,38 | 31,91 | 31,97 | -1,29% | 1,48% | 2.654.165 |
| 23/08/1996 | 32,56 | 32,74 | 32,32 | 32,38 | -1,45% | 1,28% | 2.673.029 |
| 22/08/1996 | 32,38 | 32,92 | 32,26 | 32,86 | +0,18% | 2,03% | 5.211.704 |
| 21/08/1996 | 32,74 | 33,04 | 32,68 | 32,80 | +0,00% | 1,09% | 3.814.301 |
| 20/08/1996 | 33,04 | 33,10 | 32,80 | 32,80 | -0,90% | 0,90% | 4.431.154 |
| 19/08/1996 | 33,10 | 33,10 | 32,92 | 33,10 | +0,18% | 0,54% | 3.213.168 |
| 16/08/1996 | 32,98 | 33,10 | 32,86 | 33,04 | +0,18% | 0,72% | 4.211.702 |
| 15/08/1996 | 32,50 | 33,10 | 32,44 | 32,98 | +0,91% | 2,02% | 4.881.794 |
| 14/08/1996 | 32,80 | 32,98 | 32,44 | 32,68 | -0,90% | 1,64% | 3.759.595 |
| 13/08/1996 | 32,98 | 33,34 | 32,86 | 32,98 | -0,36% | 1,45% | 7.307.704 |
| 12/08/1996 | 32,38 | 33,22 | 32,26 | 33,10 | +2,78% | 2,95% | 5.644.528 |
| 09/08/1996 | 31,91 | 32,26 | 31,91 | 32,20 | +0,93% | 1,12% | 3.673.869 |
| 08/08/1996 | 31,67 | 31,97 | 31,61 | 31,91 | +0,00% | 1,13% | 3.077.766 |
| 07/08/1996 | 32,08 | 32,08 | 31,73 | 31,91 | -0,56% | 1,12% | 3.431.152 |
| 06/08/1996 | 31,85 | 32,14 | 31,67 | 32,08 | +0,94% | 1,50% | 3.241.254 |
| 05/08/1996 | 31,79 | 31,97 | 31,61 | 31,79 | +0,19% | 1,13% | 3.370.368 |
| 02/08/1996 | 31,67 | 31,91 | 31,49 | 31,73 | +0,95% | 1,32% | 4.772.382 |
| 01/08/1996 | 30,62 | 31,43 | 30,62 | 31,43 | +2,53% | 2,63% | 5.368.066 |
| 31/07/1996 | 30,42 | 30,65 | 30,24 | 30,65 | +0,39% | 1,37% | 4.878.021 |
| 30/07/1996 | 30,30 | 30,71 | 29,88 | 30,53 | +0,99% | 2,76% | 4.025.158 |
| 29/07/1996 | 30,42 | 30,59 | 30,24 | 30,24 | -1,36% | 1,18% | 3.280.450 |
| 26/07/1996 | 30,47 | 30,83 | 30,42 | 30,65 | +0,59% | 1,37% | 3.248.381 |